Literature DB >> 3433004

Renal haemodynamics and extracellular homeostasis during the menstrual cycle.

J Brøchner-Mortensen1, P Paaby, P Fjeldborg, K Raffn, C E Larsen, J Møller-Petersen.   

Abstract

Renal haemodynamics and extracellular homeostasis during the menstrual cycle were studied in 14 healthy women (age 21-41 years) who were not taking oral contraceptives in the follicular (Period I) and luteal phase (Period II). The glomerular filtration rate [( 51Cr] EDTA clearance) and the effective renal plasma flow ([125I] hippuran clearance) increased from Period I to II by a median of 6.3% (95% confidence interval (CI): 0.6-9.2%) and 7.3% (95% CI: -0.4-22%) respectively. Serum sodium decreased from period I to II (p less than 0.01) by a median of 1 mmol/l (95% CI: -2.0 to -0.5 mmol/l) and the urinary excretion rate of potassium increased (p less than 0.02) from a median value of 35 mumol/min in Period I to 45 mumol/min in Period II. The extracellular fluid volume did not change between the two periods but the concentration of water in serum increased (p less than 0.05) from a median value of 91.7-92.0 g/100 g in Period II. Serum total protein and serum albumin both showed a borderline statistically significant decrease from Period I to II. The investigation demonstrated a number of physiological and biochemical changes from the follicular to the luteal phase, most of which in a lower scale mimic well known changes that occur during pregnancy.

Entities:  

Mesh:

Year:  1987        PMID: 3433004

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Relaxin is a potent renal vasodilator in conscious rats.

Authors:  L A Danielson; O D Sherwood; K P Conrad
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Influence of oral contraceptive agents on kidney function and protein metabolism.

Authors:  E Brändle; E Gottwald; H Melzer; H G Sieberth
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.

Authors:  Christian Ott; Agnes Bosch; Nicole Winzer; Stephanie Friedrich; Reinhard Schinzel; Frank Tegtmeier; Roland E Schmieder
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.